| Vifor (International) Inc. - Incellipan, Injektionssuspension in Fertigspritzen | | 69941 | | 01 | | Incellipan | | Injektionssuspension in Fertigspritzen | | J07BB02 | | Influenza, gereinigtes Antigen | | 25.06.2026 | | |
| | Composition | | haemagglutininum influenzae A (H5N1) (Virus- Stamm A/turkey/Turkey/1/2005 NIBRG-23) 7.5 µg, adjuvans: squalenum, polysorbatum 80 1.175 mg, sorbitani trioleas, natrii citras dihydricus et acidum citricum, natrii chloridum, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, magnesii chloridum hexahydricum, aqua ad iniectabile, q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.88 mg, kalium 0.102 mg. | | Packungsbestandteile | | | | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 10 | | | B | | Non |
|
|
